Tag | Content |
---|
EnhancerAtlas ID | HS162-06597 |
Organism | Homo sapiens |
Tissue/cell | Plasma_cell_myeloma |
Coordinate | chr21:47919700-47921710 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
IRF1 | MA0050.2 | chr21:47921164-47921185 | TATCACTTTCAGTTTTGGATT | + | 6.59 | MAFK | MA0496.2 | chr21:47920542-47920561 | CATTGCTGAGTCATCTCAA | + | 6.08 | NFE2L1 | MA0089.2 | chr21:47920543-47920558 | ATTGCTGAGTCATCT | - | 8.12 | Nfe2l2 | MA0150.2 | chr21:47920545-47920560 | TGCTGAGTCATCTCA | - | 6.27 | SOX10 | MA0442.2 | chr21:47921032-47921043 | TCCTTTGTTTT | - | 6.32 | SPIC | MA0687.1 | chr21:47921092-47921106 | GAAAAGAGGAAGAA | + | 6.47 | Sox3 | MA0514.1 | chr21:47921033-47921043 | CCTTTGTTTT | + | 6.02 | Spz1 | MA0111.1 | chr21:47920186-47920197 | AGGGTAGCAGC | + | 6.02 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_62109 | chr21:47919303-47936344 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr21 | 47920085 | 47920215 | chr21 | 47920086 | 47921115 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH21I046499 | chr21 | 47919886 | 47921982 |
|
Enhancer Sequence | TAATCCCCTC CTTTTTTTCC CAGATGAGGA AGGAAGAAAA AAAAGTCCAG CGATTGTAAC 60 TTGCTTGAGA TCAGACAGCA GCCTTAAGTG GTGAAGCCAG GGCTGATACC AGTTTTCTTG 120 ATTCCTATTC ATTTTCTTTG CTTTTTGTTG CTTTTCTGCC AAAACTGAAA GGTGACACCT 180 GTGACACGCT GGTGTTTGTG CTGGGGTCCC CATGGGTGCC GAGCTCTTTT TTGTAAGACC 240 TCGGTCATTT GGCTGGACTG GGGGCAAGTT GGGTATGTTG GGTGGCCCAC AGCTTCTGTC 300 TCATCATCCT CTGTAGTGTG CATCACTGTT GCTCTTCATG TTTTTGTTTG TTTGAGTCAG 360 CACATCTCTT GTGTTTCCAT TGAACATGTG TCCTTCTTCT GAGGCGTCCG TCTCAGATGA 420 AAGCTCACAG TGCCCTGCTC TGTCTCCACA CTGCTTCCAG CTCATAAAGG AACTGCCAAG 480 ACTACAAGGG TAGCAGCAGG CAGCATTTTC CACAGAGAAA GTTTCTCTTA GGAAAACAGC 540 CTGCTCAGAT TGTTTCTGTA GCTTTCCTGG GTGTTCCATG GCCAGAGGCT GCTGCCCACC 600 TTTCCTCAAG GTGGTGTACA GTCCATATCT TGAAAACAGC TTTTGCACTG TTGTTTGCCT 660 TCTCTGTTCA TCGTTGGTGA TTTAACTTTG TAGAAATACA TAGTTAACTC CAATTCTGAG 720 GCAGGGGCAG GAAAACAGTA GTTTTAAATG TTCTGTTACC TCATTTCTTC TCCCAGAAGC 780 TCCTTTCTAG GTGAGATGGT GCAGGAGAGC AAACAAAACA TTTGTAGTTT GAGTTTATTA 840 GCCATTGCTG AGTCATCTCA ACACTGTTTC CGGGTGGGTT AGAAATAAAA GCTTATTCAG 900 CATGAAAAAT TAGCCACAGT TCAGAATGTT TAACCGTACA GCCCTCAACT TTCCAGTGAT 960 TGTGGGGTGT CTTTAAGCAA AGCATTGAAC TCTAATGTGT GTTTGAATTA GATGTTTTCA 1020 TTCTCTGAAA AGGACTTGGC TGCAATTATT TATAATGTAG GTTTATTACC TATGTTGGTG 1080 GAAGACAGCT CCTGACTCCT GCAGATGCAG CTGTAATCAT CTCTTCCTTT CTTGTTAGTC 1140 CTAGCATCAA CATTTTGTGA TCAATTCTAA TACATTTAAA AAAAATTCTT AACTTGGACT 1200 TGATTTAATA CTTTGCTTAC AGGATTGCAA TTTTCTACAG ATTGTAGCTA CCCACATCCT 1260 AAATGTTGGA CATAGTTAAT TTGAATTTCT AAATCTCAAA AATACTCAAC TTCCCTCTTA 1320 TGACAGAAAT CATCCTTTGT TTTAGTTTCT AACACTAGAT GTGTCTTCAA TTTAAACTAA 1380 GGAAAGAAAC ATGAAAAGAG GAAGAATATA TTAAGTAAAA AATTCGAGGT AGAACATATC 1440 AGGTAAAGAT AATTTTTAAA AATATATCAC TTTCAGTTTT GGATTAAGGA AATCAAATAC 1500 ATTAAGCCTT TTTTATACAA ATGTAAATAC CTATTTTTAA AAGCAGTACT TTTAATTATA 1560 GTAGCTTCTT TTAATTATAG TAGCTTATTT TTATTTTGAA TGTAGTTTAT GTTTATTTTT 1620 ATGCAGCTTT TTTTTTTATT TTTCCACCTA GAGACAGGGT CTTGCTCTGT CACCCACGCT 1680 GGAGTACAGT GGCATGATCA TAGGTCACTG CAGCCTTGAA CTCCTGGGCT TAAGAAATTC 1740 TCCCACCTTA GCCTCCTGAG CAGCTGGGAC TATAGGCAAA TGCCAGCATG CCTAGCTAAT 1800 TTTTAAAAAT TTTTTGGAAA GATGGAGTTT TTACTGTGTT GCCCAGACTG GGCTTGAACT 1860 CCTGGGCTCA AGTGATCCTC ATGCCTTGGC CTTTCAAAAT GTTAGGATTA TAGGAATGAG 1920 CCACTGCTCC CAGCCATTAT ATAGCTGTTT TAAAAAACTA CTTGTAGTAC ATGTATGTAT 1980 ACCATGTATA CCTTTTTTTC CATATATACT 2010
|